PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 8.23

Change

+0.22 (+2.75)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+1.47 (+4.17%)

USD 11.38B
QLD ProShares Ultra QQQ

+2.33 (+2.38%)

USD 7.32B
FNGU MicroSectors FANG+ Index 3X Le..

+22.98 (+5.73%)

USD 5.28B
SSO ProShares Ultra S&P500

+1.54 (+1.75%)

USD 5.17B
UPRO ProShares UltraPro S&P500

+2.18 (+2.62%)

USD 4.05B
TECL Direxion Daily Technology Bull..

+2.71 (+3.23%)

USD 3.22B
YINN Direxion Daily FTSE China Bull..

+5.09 (+10.89%)

USD 1.83B
USD ProShares Ultra Semiconductors

+4.19 (+3.50%)

USD 1.18B
LABU Direxion Daily S&P Biotech Bul..

+2.94 (+2.45%)

USD 0.94B
DPST Direxion Daily Regional Banks ..

+5.29 (+5.89%)

USD 0.80B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.19% 17% F 44% F
Dividend Return 1.00% 54% F 18% F
Total Return 7.20% 17% F 38% F
Trailing 12 Months  
Capital Gain 22.11% 13% F 58% F
Dividend Return 1.72% 48% F 24% F
Total Return 23.83% 12% F 53% F
Trailing 5 Years  
Capital Gain -34.50% 26% F 14% F
Dividend Return 2.10% 34% F 6% D-
Total Return -32.40% 26% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain -2.96% N/A N/A 23% F
Dividend Return -2.47% N/A N/A 14% F
Total Return 0.49% N/A N/A 12% F
Risk Return Profile  
Volatility (Standard Deviation) 105.69% N/A N/A 7% C-
Risk Adjusted Return -2.34% N/A N/A 23% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike